DaVita Inc. (NYSE:DVA) Given Average Recommendation of “Hold” by Analysts

Shares of DaVita Inc. (NYSE:DVA) have been given an average recommendation of “Hold” by the six research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $166.33.

A number of research firms recently weighed in on DVA. Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. Finally, Barclays upped their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th.

Institutional Trading of DaVita

Hedge funds have recently modified their holdings of the company. Copia Wealth Management purchased a new stake in shares of DaVita during the fourth quarter valued at about $30,000. SBI Securities Co. Ltd. acquired a new position in shares of DaVita during the fourth quarter valued at about $41,000. Coppell Advisory Solutions LLC increased its holdings in shares of DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after acquiring an additional 100 shares in the last quarter. Quarry LP acquired a new position in shares of DaVita during the third quarter valued at about $60,000. Finally, Canada Post Corp Registered Pension Plan acquired a new position in shares of DaVita during the fourth quarter valued at about $55,000. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Trading Up 1.7 %

NYSE DVA opened at $143.56 on Friday. The company’s 50-day moving average price is $158.92 and its 200-day moving average price is $157.60. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The stock has a market cap of $11.48 billion, a PE ratio of 13.37, a PEG ratio of 1.07 and a beta of 0.99. DaVita has a 12 month low of $125.64 and a 12 month high of $179.60.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities research analysts forecast that DaVita will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.